pof8 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
pof8 antibody; SPAC17G6.17 antibody; Protein pof8 antibody
Target Names
pof8
Uniprot No.

Target Background

Function
Pof8 is an RNA-binding protein essential for the assembly of the telomerase ribonucleoprotein (RNP) complex. It specifically binds to telomerase RNA (ter1) and facilitates the formation of the complex between ter1 and the catalytic subunit (trt1). Telomerase is a ribonucleoprotein enzyme crucial for maintaining cell division by adding new telomeric repeats to chromosome ends.
Gene References Into Functions
  1. In Schizosaccharomyces pombe, Pof8, a protein related to p65, and its xRRM domain play a crucial role in promoting the assembly of RNA polymerase II-encoded telomerase RNA with TERT. Additionally, Pof8 contributes to the repression of noncoding RNA transcription at telomeres. PMID: 29422503
Database Links
Subcellular Location
Chromosome, telomere. Nucleus. Cytoplasm.

Q&A

What is Pof8 and why are antibodies against it valuable for telomerase research?

Pof8 is a La-related protein (LARP) family member and a constitutive component of active telomerase in fission yeast (Schizosaccharomyces pombe). Originally misannotated as an F-box protein, structural analysis has revealed that Pof8 contains a La motif and RNA recognition motifs (RRMs) that most closely resemble those in the human LARP family .

Pof8 is critical for telomerase function as it:

  • Promotes binding of the Lsm2-8 complex to telomerase RNA (TER1)

  • Facilitates recruitment of the catalytic subunit (Trt1/TERT)

  • Ensures TER1 stability and proper telomerase assembly

  • Contributes to telomere maintenance

Antibodies against Pof8 are valuable research tools because nearly 100% of active telomerase is associated with Pof8, making it a bona fide component of the active holoenzyme . Currently available antibodies include:

  • Polyclonal rabbit antibodies against recombinant Schizosaccharomyces pombe Pof8

  • Custom-made antibodies used in published research studies

How can Pof8 antibodies be effectively used in telomerase research?

Pof8 antibodies have been successfully employed in several key experimental applications:

Immunoprecipitation (IP) for telomerase activity assays:
Pof8 antibodies can immunoprecipitate active telomerase complexes. In published studies, FLAG-tagged Pof8 immunoprecipitates displayed robust telomerase activity . The specificity of these IPs can be confirmed by:

  • Northern blotting to detect co-precipitation of TER1 RNA

  • Absence of non-specific RNAs like snR101

  • Direct telomerase activity assays of the immunoprecipitates

Protein complex identification:
Pof8 antibodies have been instrumental in identifying novel telomerase components:

  • Epitope-tagged Pof8 immunoprecipitation followed by silver staining and mass spectrometry identified Thc1 and Bmc1 as Pof8 binding partners

  • Western blotting of immunoprecipitates confirmed physical interactions between Pof8, Thc1, and Bmc1

RNA-protein interaction studies:
UV cross-linking experiments with FLAG-tagged Pof8 followed by denaturing immunoprecipitation have demonstrated direct Pof8-TER1 interactions .

What controls should be included when using Pof8 antibodies in immunoprecipitation experiments?

When designing experiments using Pof8 antibodies, the following controls are essential:

Negative controls:

  • Untagged/wild-type strains when using epitope tag antibodies

  • Pre-immune serum for polyclonal antibodies

  • IgG isotype controls for monoclonal antibodies

  • Extracts from pof8Δ strains to control for non-specific binding

Positive controls:

  • Parallel immunoprecipitation of known telomerase components (e.g., Lsm proteins)

  • Detection of expected co-precipitating factors (TER1, Trt1)

Specificity controls:

  • RNase A treatment to distinguish RNA-dependent from direct protein-protein interactions

  • Testing for presence/absence of unrelated RNAs (e.g., U6 snRNA shows minimal co-precipitation with Pof8)

  • Sequential immunoprecipitation experiments to determine the proportion of a factor associated with Pof8 (as demonstrated with Lsm4-cMyc and FLAG-Pof8)

How can I validate whether my Pof8 antibody is detecting functionally relevant Pof8-RNA interactions?

Validation of Pof8 antibodies for RNA interaction studies requires multiple complementary approaches:

Functional validation through reconstitution experiments:
Researchers have demonstrated that recombinant Pof8-Thc1 complex added to pof8Δ cell extracts increases:

  • TER1 recovery in Lsm4 immunoprecipitations (4-fold increase)

  • Telomerase activity (up to 9-fold increase)

This approach can confirm that your antibody is detecting functionally relevant Pof8.

RNA specificity assessment:

  • Compare immunoprecipitation of TER1 versus other Lsm-associated RNAs

  • Overlay differential expression data from pof8 versus pof8Δ cells with Lsm8 immunoprecipitation data

  • Quantify enrichment of different RNAs in Pof8 immunoprecipitates

Research has shown that among 35 RNAs enriched in Lsm8 immunoprecipitates, TER1 was the only transcript both bound by Lsm8 and reduced in pof8Δ cells, confirming the specificity of Pof8 for telomerase RNA .

Structural domain mutant analysis:
Create strains with mutations in the functional domains of Pof8:

  • xRRM domain (e.g., pof8-R343A)

  • N-terminal regions encompassing the putative divergent La-module

  • α3 helix truncations

These can be used to validate antibody specificity and determine which interactions are dependent on which domains .

What factors might affect Pof8 antibody performance in immunoprecipitation and Western blotting?

Several factors can impact the success of Pof8 antibody-based experiments:

Complex stability factors:

  • The stability of Pof8-TER1 interactions is enhanced by Thc1 and Bmc1, with a 15-fold reduction in TER1 co-IP with Pof8 when both thc1 and bmc1 are absent

  • Consider extracting Pof8 under conditions that preserve these stabilizing interactions

RNA-dependent interactions:

  • Some Pof8 interactions (e.g., with Trt1) are RNA-dependent and sensitive to RNase treatment

  • Ensure RNase inhibitors are included in extraction buffers when studying RNA-dependent complexes

Expression level considerations:

  • Pof8 is a constitutive component of telomerase, so its expression level may be relatively low

  • pof8Δ cells show reduced TER1 levels (4-fold reduction) which may further complicate detection of interacting factors

Recommended IP conditions from published research:

  • Express Pof8 under its endogenous promoter to maintain physiological levels

  • For UV crosslinking experiments, immunoprecipitate under denaturing conditions to identify direct RNA-protein interactions

  • For complex analyses, use native conditions with appropriate salt concentrations to maintain complex integrity

How do antibody-based approaches compare with genetic methods for studying Pof8 function?

Both antibody-based and genetic approaches offer complementary insights into Pof8 function:

Antibody-based approaches advantages:

  • Allow isolation of native complexes and assessment of biochemical activities

  • Enable quantification of complex stoichiometry (e.g., finding that nearly 100% of active telomerase contains Pof8)

  • Permit identification of transient or conditional interactions

  • Can distinguish between different functional pools of Pof8

Genetic approaches advantages:

  • pof8Δ strains show clear phenotypes (30% shorter telomeres, reduced TER1 stability)

  • Domain mutations can separate different functions (e.g., xRRM domain mutants show different effects on telomeric gene silencing versus telomerase activity)

  • Allow assessment of genetic interactions with other factors (pof8Δ trt1Δ shows telomere loss upon restreaking)

Complementary use of both approaches:
The most comprehensive studies have combined:

  • Genetic deletion or mutation of pof8

  • Biochemical analysis using antibodies against Pof8 or interacting factors

  • Functional reconstitution experiments with recombinant proteins

How should I interpret differences in Pof8 antibody immunoprecipitation efficiency between experimental conditions?

Variations in immunoprecipitation efficiency can provide valuable insights:

Quantitative interpretation table:

Experimental ConditionTER1 Co-IP EfficiencyTelomerase ActivityBiological Interpretation
Wild-typeHigh (reference)High (reference)Normal telomerase assembly
thc1ΔReducedReducedThc1 stabilizes Pof8-TER1 interaction
bmc1ΔReducedReducedBmc1 contributes to complex stability
thc1Δ bmc1Δ15-fold reductionSeverely reducedThc1 and Bmc1 cooperatively stabilize Pof8 on TER1
xRRM domain mutantsVariable reductionVariable reductionDifferent residues contribute differentially to RNA binding

When analyzing immunoprecipitation data:

  • Normalize appropriately: Express results relative to input material and appropriate controls

  • Consider complex composition: Reduced IP efficiency may reflect destabilization of specific subcomplexes rather than complete loss of interaction

  • Assess RNA dependence: Compare results with and without RNase treatment to distinguish direct versus RNA-mediated interactions

What methodological adaptations are needed when using Pof8 antibodies to study non-telomerase functions?

Pof8 has functions beyond telomerase assembly, particularly in regulating non-coding RNA expression at telomeres. When studying these alternative functions:

For studying telomeric transcription regulation:

  • Use RT-PCR-based assays to monitor poly(A)+ lncRNAs species (poly(A)+TERRA, ARRRET, αARRET)

  • Include appropriate controls (ter1Δ, rap1Δ, ccq1Δ strains) that show increased expression of telomeric transcripts

  • Design experiments to distinguish between TERRA and other telomeric transcripts

  • Consider that different Pof8 domains contribute differently to telomeric silencing versus telomerase function

For studying broader RNA regulation:
Research has shown that deletion of pof8 affects expression of only a small number of transcripts:

  • 5 protein-encoding transcripts and 13 non-coding RNAs (including TER1) were downregulated

  • A small number of transcripts were upregulated, including tlh2 (a locus in subtelomeric DNA)

When using Pof8 antibodies for chromatin immunoprecipitation:

  • Include specific PCR primers for telomeric and subtelomeric regions

  • Consider that Pof8 may interact differently with chromatin depending on whether it's bound to telomerase RNA or other RNAs

  • Include appropriate controls to distinguish between direct DNA binding and RNA-mediated chromatin association

What emerging applications of Pof8 antibodies might advance telomerase research?

Several promising research directions could benefit from Pof8 antibody applications:

Structural studies of telomerase assembly:

  • Using Pof8 antibodies for single-particle cryo-EM analysis of telomerase complexes

  • Applying proximity labeling approaches with Pof8 antibodies to map spatial organization of telomerase components

  • Investigating conformational changes in Pof8 during telomerase assembly and activation

Dynamic regulation studies:

  • Examining cell-cycle dependent changes in Pof8-telomerase interactions

  • Investigating post-translational modifications of Pof8 that might regulate its function

  • Studying potential redistribution of Pof8 under cellular stress conditions

Evolutionary conservation analysis:
Pof8 shares structural similarities with telomerase subunits from ciliated protozoa (p65 from Tetrahymena and p43 from Euplotes), despite differences in telomerase RNA transcription (RNA polymerase II in fission yeast versus RNA polymerase III in ciliates) .

Antibodies against Pof8 could help identify functional homologs in other species where sequence conservation might be low but structural features are preserved.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.